Benzodiazepine-GABAA receptors in idiopathic generalized epilepsy measured with [11C]flumazenil and positron emission tomography. 1995

M C Prevett, and A A Lammertsma, and D J Brooks, and P A Bartenstein, and P N Patsalos, and D R Fish, and J S Duncan
MRC Cyclotron Unit, Hammersmith Hospital, London, England.

The neurochemical basis of absence seizures and the mechanism of their suppression by valproate (VPA) are uncertain. We used positron emission tomography (PET) to determine whether an abnormality of [11C]flumazenil binding to benzodiazepine (BZD)-GABAA receptors exists in patients with childhood and juvenile absence epilepsy and to examine the effects of VPA on [11C]flumazenil binding. The regional cerebral volume of distribution (Vd) of [11C]flumazenil in patients not treated with VPA was not different from that in normal controls; Vd was lower in patients treated with VPA, and the number of receptors available for binding was significantly reduced in such patients as compared with normal controls. There was no evidence of a primary abnormality of the BZD-GABAA receptor in childhood and juvenile absence epilepsy (CAE/JAE), but the data suggest that treatment with VPA is associated with a reduction in [11C]flumazenil binding that may be relevant to its mode of action in CAE/JAE.

UI MeSH Term Description Entries
D008297 Male Males
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D004832 Epilepsy, Absence A seizure disorder usually occurring in childhood characterized by rhythmic electrical brain discharges of generalized onset. Clinical features include a sudden cessation of ongoing activity usually without loss of postural tone. Rhythmic blinking of the eyelids or lip smacking frequently accompanies the SEIZURES. The usual duration is 5-10 seconds, and multiple episodes may occur daily. Juvenile absence epilepsy is characterized by the juvenile onset of absence seizures and an increased incidence of myoclonus and tonic-clonic seizures. (Menkes, Textbook of Child Neurology, 5th ed, p736) Akinetic Petit Mal,Epilepsy, Minor,Petit Mal Epilepsy,Pyknolepsy,Absence Seizure Disorder,Childhood Absence Epilepsy,Epilepsy Juvenile Absence,Epilepsy, Absence, Atypical,Epilepsy, Petit Mal,Juvenile Absence Epilepsy,Pykno-Epilepsy,Seizure Disorder, Absence,Absence Epilepsy,Absence Epilepsy, Childhood,Absence Epilepsy, Juvenile,Absence Seizure Disorders,Epilepsy, Childhood Absence,Epilepsy, Juvenile Absence,Minor Epilepsy,Petit Mal, Akinetic,Pykno Epilepsy,Pyknolepsies,Seizure Disorders, Absence
D005260 Female Females
D005442 Flumazenil A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses. Flumazepil,Anexate,Lanexat,Ro 15-1788,Romazicon,Ro 15 1788,Ro 151788
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M C Prevett, and A A Lammertsma, and D J Brooks, and P A Bartenstein, and P N Patsalos, and D R Fish, and J S Duncan
October 1997, Epilepsia,
M C Prevett, and A A Lammertsma, and D J Brooks, and P A Bartenstein, and P N Patsalos, and D R Fish, and J S Duncan
September 1994, Epilepsy research,
M C Prevett, and A A Lammertsma, and D J Brooks, and P A Bartenstein, and P N Patsalos, and D R Fish, and J S Duncan
May 2000, Annals of neurology,
M C Prevett, and A A Lammertsma, and D J Brooks, and P A Bartenstein, and P N Patsalos, and D R Fish, and J S Duncan
April 1986, European journal of pharmacology,
M C Prevett, and A A Lammertsma, and D J Brooks, and P A Bartenstein, and P N Patsalos, and D R Fish, and J S Duncan
December 2004, Neurology India,
M C Prevett, and A A Lammertsma, and D J Brooks, and P A Bartenstein, and P N Patsalos, and D R Fish, and J S Duncan
May 2001, Annals of neurology,
M C Prevett, and A A Lammertsma, and D J Brooks, and P A Bartenstein, and P N Patsalos, and D R Fish, and J S Duncan
December 1995, Epilepsia,
M C Prevett, and A A Lammertsma, and D J Brooks, and P A Bartenstein, and P N Patsalos, and D R Fish, and J S Duncan
December 1999, Neurology,
M C Prevett, and A A Lammertsma, and D J Brooks, and P A Bartenstein, and P N Patsalos, and D R Fish, and J S Duncan
July 1992, European journal of pharmacology,
M C Prevett, and A A Lammertsma, and D J Brooks, and P A Bartenstein, and P N Patsalos, and D R Fish, and J S Duncan
August 2003, American journal of veterinary research,
Copied contents to your clipboard!